Kulikowska, J.; Kapica-Topczewska, K.; Gudowska-Sawczuk, M.; Kulczyńska-Przybik, A.; Bazylewicz, M.; Mirończuk, A.; Czarnowska, A.; Brola, W.; Mroczko, B.; Kochanowicz, J.;
et al. Analysis of the Presence and Levels of IgG Antibodies Directed against the S1 Protein Receptor Binding Domain and the N Protein of SARS-CoV-2 in Patients with Multiple Sclerosis Treated with Immunomodulatory Therapies. Vaccines 2024, 12, 255.
https://doi.org/10.3390/vaccines12030255
AMA Style
Kulikowska J, Kapica-Topczewska K, Gudowska-Sawczuk M, Kulczyńska-Przybik A, Bazylewicz M, Mirończuk A, Czarnowska A, Brola W, Mroczko B, Kochanowicz J,
et al. Analysis of the Presence and Levels of IgG Antibodies Directed against the S1 Protein Receptor Binding Domain and the N Protein of SARS-CoV-2 in Patients with Multiple Sclerosis Treated with Immunomodulatory Therapies. Vaccines. 2024; 12(3):255.
https://doi.org/10.3390/vaccines12030255
Chicago/Turabian Style
Kulikowska, Joanna, Katarzyna Kapica-Topczewska, Monika Gudowska-Sawczuk, Agnieszka Kulczyńska-Przybik, Marcin Bazylewicz, Anna Mirończuk, Agata Czarnowska, Waldemar Brola, Barbara Mroczko, Jan Kochanowicz,
and et al. 2024. "Analysis of the Presence and Levels of IgG Antibodies Directed against the S1 Protein Receptor Binding Domain and the N Protein of SARS-CoV-2 in Patients with Multiple Sclerosis Treated with Immunomodulatory Therapies" Vaccines 12, no. 3: 255.
https://doi.org/10.3390/vaccines12030255
APA Style
Kulikowska, J., Kapica-Topczewska, K., Gudowska-Sawczuk, M., Kulczyńska-Przybik, A., Bazylewicz, M., Mirończuk, A., Czarnowska, A., Brola, W., Mroczko, B., Kochanowicz, J., & Kułakowska, A.
(2024). Analysis of the Presence and Levels of IgG Antibodies Directed against the S1 Protein Receptor Binding Domain and the N Protein of SARS-CoV-2 in Patients with Multiple Sclerosis Treated with Immunomodulatory Therapies. Vaccines, 12(3), 255.
https://doi.org/10.3390/vaccines12030255